Skip to main content
Dhanuka Agritech Ltd. logo

Dhanuka Agritech Ltd. — Investor Relations & Filings

Ticker · DHANUKA ISIN · INE435G01025 LEI · 335800E4DLZIC7MSG125 BSE.NS Manufacturing
Open in API
Filings indexed 1,595 across all filing types
Latest filing 2025-12-10 Regulatory Filings
Country IN India
Listing BSE.NS DHANUKA

About Dhanuka Agritech Ltd.

https://www.dhanuka.com/

Dhanuka Agritech Ltd. specializes in the manufacturing and marketing of a comprehensive range of crop protection solutions, including insecticides, herbicides, fungicides, and plant growth regulators. The company maintains strategic technical collaborations with several global chemical innovators to bring advanced formulations to the agricultural sector. Its product portfolio is supported by a robust research and development infrastructure and an extensive distribution network that facilitates the delivery of integrated pest management and soil health solutions. The organization focuses on enhancing agricultural productivity through the provision of high-quality inputs and technical advisory services. By leveraging a strong field force, it provides training and support to optimize crop yields and resource efficiency, ensuring the effective application of its diverse chemical and biological offerings.

Recent filings

Filing Released Lang Actions
Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges regarding a demand order received under the Central Goods & Service Tax (GST) from a regulatory authority. It discloses the nature of the demand, the company's assessment of the demand, and its intended response. The document references SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content is an announcement of a regulatory or legal matter affecting the company, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis. The document is relatively short (3269 characters) and serves as a regulatory announcement about a legal/tax issue. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-12-10 English
Transcript of conference call held on 31st October, 2025 with Analysts/Investors to discuss the Un-audited Financial Results of the Company for the Quarter & Half-year ended on September 30, 2025.
Call Transcript Classification · 100% confidence The document is a transcript of a conference call held on October 31, 2025, discussing the un-audited financial results for the quarter and half-year ended September 30, 2025. It includes detailed management commentary, financial performance data, and a Q&A session with analysts and investors. The presence of a full transcript with management discussion and Q&A clearly identifies this as a Call Transcript (CT). The document is lengthy (15,000 characters) and contains the full text of the call, not just an announcement or summary, so it is not an Earnings Release (ER) or Report Publication Announcement (RPA).
2025-11-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of a conference call held on October 31, 2025, discussing the un-audited financial results for the quarter and half-year ended September 30, 2025. It includes detailed management commentary, financial performance data, and a Q&A session with analysts and investors. The presence of a full transcript with management speaking and Q&A indicates this is a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or summary. Therefore, it fits the definition of a Call Transcript rather than an Earnings Release or Regulatory Filing.
2025-11-04 English
Copies of Financial results for the Quarter and Half Year ended on 30th September 2025 Published in the newspapers.
Regulatory Filings
2025-11-01 English
Copy of Newspaper Publication
Regulatory Filings
2025-11-01 English
Audio Recording of Analysts/Investors Call pertaining to the Un-Audited Financial Results for the Quarter and Half-Year Ended September 30, 2025
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the audio recording link of an analysts/investors call about the un-audited financial results for the quarter and half-year ended September 30, 2025. It references the financial results but does not contain the results themselves or detailed financial data. The document is short (1588 characters) and primarily serves as an announcement providing a link to the call recording. According to the rules, such announcements about calls or reports without the actual transcript or financial data should be classified as Regulatory Filings (RNS).
2025-10-31 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.